Mo1539: ANTI-TNF WITHDRAWAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN ENDOSCOPIC REMISSION: A PROSPECTIVE STUDY
Remi Mahmoud(University Medical Center Utrecht), Bas Oldenburg(University Medical Center Utrecht), Daan de Koning, Dilek Akol-Simsek, Frank Hoentjen(Radboud University Nijmegen), Itta M. Minderhoud(Tergooi), Ben Witteman(Ziekenhuis Gelderse Vallei), Nofel Mahmmod(St. Antonius Ziekenhuis), Maurice Lutgens(Elisabeth-TweeSteden Ziekenhuis), Carmen S. Horjus Talabur Horje(Rijnstate Hospital), Edo Savelkoul(Radboud University Nijmegen), Rogier Goetgebuer(Erasmus MC), Sebastiaan van Tuyl, Bindia Jharap(Meander Medisch Centrum), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Jeroen M. Jansen(OLVG), Petra G. Van Boeckel(St. Antonius Ziekenhuis), Wout Mares(Ziekenhuis Gelderse Vallei), Jean‐Frédéric Colombel(Mount Sinai Hospital)
Cited by 0
Related Papers
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k